Polyphenol Enriched Extra-virgin Olive Oil and Postprandial Glycemia in Type 1 Diabetes (DOP)
DOP
1 other identifier
interventional
22
1 country
1
Brief Summary
The aims of this study are to investigate the short term effects of MUFA alone vs. MUFA plus Polyphenols contained in the extra-virgin olive oil (EVOO) on the postprandial glycemic response in patients with type 1 diabetes and to explore the possible mechanisms through which MUFA alone or MUFA plus Polyphenols contained in EVOO could influence postprandial glycaemia.The intervention will be preceded by two-weeks run-in period during which participants will consume an usual olive oil, fill-in a 7-day dietary food record and practice continuous blood glucose monitoring (CGM) in order to optimize basal insulin infusion values and the insulin-to-glycemic load ratio.The study will be conducted according to a randomized cross-over design. The participants will consume, in random order at a distance of one week from each other, a meal-test seasoned with extra virgin olive oil rich in polyphenols (EVOO + POLY) or a meal-test seasoned with olive oil poor in polyphenols (OO-POLY). Upon fasting and during the 6 hours following the meal, patients will undergo to:
- 1.Venous blood drawing samples for the evaluation of gastrointestinal hormones, markers of systemic inflammation and oxidative stress.
- 2.Breath test with 13C-octanoic acid, for the study of gastric emptying. During the experimental period the participants will undergo to continuous glucose monitoring wearing sensors 7 days/week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2020
CompletedFirst Submitted
Initial submission to the registry
February 18, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedFebruary 24, 2021
February 1, 2021
8 months
February 18, 2021
February 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the between-group difference in postprandial glycemia changes after the dietary interventions
Postprandial incremental area (iAUC)
6 hours
Study Arms (2)
EVOO+POLY
EXPERIMENTALAcute test meal
OO-POLY
ACTIVE COMPARATORAcute test meal
Interventions
Eligibility Criteria
You may qualify if:
- Treatment with continuous subcutaneous insulin infusion for at least 6 months
- HbA1c less than 8.5% (69 mmol/mol)
You may not qualify if:
- Pregnancy and breastfeeding
- Any other chronic or acute disease apart diabetes seriously affecting health status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federico II University
Napoli, Naples, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
February 18, 2021
First Posted
February 21, 2021
Study Start
April 1, 2019
Primary Completion
November 20, 2019
Study Completion
November 20, 2020
Last Updated
February 24, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share